US2014223607A1PendingUtilityA1
Transformation system in camelina sativa
Est. expiryNov 13, 2020(expired)· nominal 20-yr term from priority
C12N 15/8205
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to plant biotechnology and specifically to a method for genetically transforming Camelina sativa with Agrobacterium -mediated transformation system. It comprises Camelina sativa for producing homologous and heterologous recombinant products including oil and protein products and assessing and screening the efficacy of plant transformation. Also disclosed are transgenic Camelina sativa plants, seeds as well as cells, cell-lines and tissue of Camelina sativa.
Claims
exact text as granted — not AI-modified1 - 29 . (canceled)
30 . A method of transferring a recombinant DNA construct into a Camelina sativa plant cell, the method comprising:
a) contacting one or more plant cells from Camelina sativa with Agrobacterium, wherein the Agrobacterium comprises a recombinant DNA construct; b) maintaining the one or more plant cells in contact with the Agrobacterium under conditions such that Agrobacterium -mediated genetic transformation of the one or more plant cells occurs, forming one or more plant cells comprising the recombinant DNA construct.
31 . The method of claim 30 , further comprising producing a plant or plant part comprising the recombinant DNA construct from the one or more plant cells comprising the recombinant DNA construct.
32 . The method of claim 30 , wherein the Agrobacterium is Agrobacterium tumefaciens.
33 . The method of claim 30 , wherein the recombinant DNA construct is a vector comprising an optional selectable marker gene.
34 . The method of claim 33 , wherein the selectable marker gene comprises an antibiotic resistance gene.
35 . The method of claim 34 , wherein the antibiotic resistance gene comprises a neomycin phosphotransferase (npt ll) gene or a hygromycin phosphotransferase (hpt) gene.
36 . The method of claim 30 , wherein the Camelina sativa plant cell is found in an organ selected from the group consisting of hypocotyl, cotyledon, stem, leaf, and other plant organs.
37 . The method of claim 30 , wherein the recombinant DNA construct comprises at least one heterologous gene, at least one promoter sequence, and an optional selectable marker gene.
38 . The method of claim 30 , wherein, in step b), the plant cell is exposed to a growth medium comprising about 2% sucrose.
39 . The method of claim 38 , wherein the growth media further comprises one or more hormones.
40 . The method of claim 39 , wherein the one or more hormones are selected from the group consisting of auxin and cytokinin.
41 . The method of claim 40 , wherein the auxin is NAA (α-napthaleneacetic acid) and the cytokinin is BAP (6-benzylaminopurine).
42 . The method of claim 30 , wherein the plant cell is maintained in contact with the Agrobacterium for at least two days.
43 . The method of claim 30 , wherein the one or more plant cells comprising the recombinant DNA construct produce a heterologous product.
44 . The method of claim 43 , wherein the heterologous product is a protein or a metabolite.
45 . A Camelina sativa plant cell comprising a recombinant DNA construct, characterized in that said plant cell is obtained by the method according to claim 30 .
46 . A Camelina sativa plant or plant part comprising a recombinant DNA construct, characterized in that said plant or plant part is derived from a plant cell obtained by the method according to claim 30 .Join the waitlist — get patent alerts
Track US2014223607A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.